CALLIDITAS THERAPEUTICS AB SER'B'NPV earnings per share and revenue

0A5R earnings per share for the last quarter are -0.34 SEK whereas the estimation was -0.94 SEK which accounts for 64.00% surprise. Company revenue for the same period amounts to 451.56 M SEK despite the estimated figure of 360.45 M SEK. Estimated earnings per share for the next quarter are -0.83 SEK, and revenue is expected to reach 382.50 M SEK. Also watch annual changes over time to get a bigger picture of 0A5R earnings per share and revenue dynamics.